Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists, inhibitors |
Mechanism ADRA1 agonists(Adrenergic receptor alpha-1 agonists), COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Australia (21 Jun 2005), |
Regulation- |
Molecular FormulaC9H14ClNO2 |
InChIKeyOCYSGIYOVXAGKQ-FVGYRXGTSA-N |
CAS Registry61-76-7 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Congestion of nasal mucosa | Australia | 21 Jun 2005 | |
Pain | Australia | 21 Jun 2005 | |
Common Cold | China | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Respiratory Tract Infections | Phase 2 | Ireland | 01 Mar 2010 |